Form 8-K · Current report
Goldman Sachs 8-K, filed Aug 11, 2026
- Filed
- CIK
- 0000886982
- Accession no.
- 0001193125-26-344912
Summary
Goldman Sachs filed a Form 8-K after redeeming all outstanding shares of its 3.65% Fixed-Rate Reset Non-Cumulative Preferred Stock, Series U on August 10, 2026, and filing a Certificate of Elimination for that series with the Delaware Secretary of State on August 11, 2026. A restated certificate filed the same day reflects the elimination of Series U and the terms of its 6.500% Fixed-Rate Reset Non-Cumulative Preferred Stock, Series AA.
Key points
- All outstanding shares of Goldman Sachs's Series U Preferred Stock were redeemed on August 10, 2026.
- Goldman Sachs filed a Certificate of Elimination for the Series U Preferred Stock with the Delaware Secretary of State on August 11, 2026.
- A restated certificate of incorporation filed on August 11, 2026 reflects the Series U elimination and the terms of the Series AA Preferred Stock.
- The Form 8-K included Exhibit 3.1, the Certificate of Elimination, and Exhibit 3.2, the restated certificate of incorporation.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 5.03Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
- 9.01Financial Statements and Exhibits
From the filing
Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year. On August 11, 2026, the Company filed a Certificate of Elimination to its Restated Certificate of Incorporation with the Secretary of State of the State of Delaware eliminating from the Restated Certificate of Incorporation all matters set forth in the Certificate of Designations with respect to its 3.65% Fixed-Rate Reset Non-Cumulative Preferred Stock, Series U (the “Series U Preferred Stock”). All outstanding shares of the Series U Preferred Stock were redeemed on August 10, 2026. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.